Skip to main content
Back to Store Details

COVID-19 Vaccine at
631 Washington St., Boston, MA 02111

CVS Health offers COVID-19 Vaccines. Limited appointments now available for patients who qualify.

The FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines. As of August 23, 2021, the FDA has issued full approval of the Pfizer-BioNTech vaccine for ages 16+.

The previously issued Emergency Use Authorizations (EUA) for the Pfizer-BioNTech vaccine for those ages 12 to 15 and third doses for the immunocompromised, as well as EUAs for COVID-19 vaccines manufactured by Moderna and Johnson & Johnson's Janssen, remain in effect. An EUA gives the FDA authority to allow unapproved medical products to be used in emergencies when no approved alternatives are available. Other COVID-19 vaccines are in development and will be reviewed by the FDA under EUA. Find the current status of the vaccine approvals and EUAs.

CVS Health has administered more than 41 million COVID-19 tests and 50 million COVID-19 vaccines. The Company maintains a strong commitment to vaccine and testing equity and continues to optimize site locations and targeted outreach initiatives in order to reach vulnerable populations.

Following guidelines set by ACIP and the CDC all individuals who are over the age of 18 are eligible to receive a Moderna or Pfizer-BioNTech COVID-19 booster shot at least six months after their primary two-dose vaccination series.

The FDA and CDC also authorized the administration of a booster dose of the Pfizer-BioNTech vaccine for patients ages 16-17 years, six months after receiving the second dose of their primary COVID-19 vaccination series.

Eligible individuals do not need to receive a booster shot that matches the formulation of their primary series. If individuals choose a booster dose that differs from their primary vaccine series, the manufacturers recommend individuals should check with their health care provider regarding the timing of the booster dose.

Additionally, individuals who are 18 years and old and received the Johnson & Johnson (Janssen) COVID-19 vaccine may receive a single booster dose of Johnson & Johnson (Janssen), Moderna, or Pfizer-BioNTech COVID-19 vaccine at least two months after receiving their primary vaccination.

Patients who received a Johnson & Johnson (Janssen) COVID-19 vaccine and prefer to receive a Johnson & Johnson (Janssen) booster are encouraged to contact their primary care provider for the best next steps or refer to vaccines.gov for more information.

As of November 19, the Pfizer-BioNTech and Moderna COVID-19 vaccines boosters are authorized for eligible individuals age 18 and above, following FDA authorization, and under guidelines set by ACIP and the CDC.

On December 9, the FDA and CDC authorized the administration of a booster dose of the Pfizer-BioNTech vaccine for patients ages 16-17 years, six months after receiving the second dose of their primary COVID-19 vaccination series.

Additionally, individuals who are 18 years and older and received the Johnson & Johnson (Janssen) COVID-19 vaccine may receive a single booster dose of Johnson & Johnson (Janssen), Moderna, or Pfizer-BioNTech COVID-19 vaccine at least two months after receiving their primary vaccination.

CVS Pharmacy will provide Moderna or Pfizer-BioNTech vaccine booster shots to eligible individuals who received the Johnson & Johnson (Janssen) vaccine as their primary vaccination. CVS Pharmacy will not be offering booster shots of the Johnson & Johnson (Janssen) vaccine.

Moderna and Pfizer-BioNTech booster shots for eligible individuals 18+ are available at select CVS Pharmacy and MinuteClinic locations.

In addition, as of Friday, December 10, teens ages 16-17 years became eligible to receive the Pfizer-BioNTech COVID-19 booster shot at CVS Pharmacy locations currently carrying this vaccine. A parent or legal guardian must complete the online registration on CVS.com for minors up to age 17. Teens 16 and older do not need to be accompanied by an adult to their vaccination appointment unless required by local or state law.

Yes, the booster is available at no cost to any eligible patient either through insurance or a federal program for the uninsured.

Patients interested in receiving the Pfizer-BioNTech or Moderna COVID-19 booster are strongly encouraged to make an appointment at CVS.com or MinuteClinic.com . Advanced scheduling is recommended for patients looking to receive a COVID-19 vaccine from a specific manufacturer to ensure that it is available at the clinic of their choice. At this time, each participating CVS Pharmacy or MinuteClinic is offering either the Pfizer-BioNTech or the Moderna vaccine. Same-day or walk-in vaccination appointments may be possible but are subject to local demand.

Yes. According to the CDC, eligible individuals, including children, may receive the seasonal flu vaccine at the same time they are receiving the Pfizer-BioNTech or Moderna COVID-19 vaccine. There is no need to stagger vaccinations. Additionally, if an individual has already received a flu shot, they can receive their COVID-19 vaccine at any time.

The Delta variant causes more infections and spreads faster than the original SARS-CoV-2 strain of the virus that causes COVID-19. The Omicron variant likely will spread more easily than the original SARS-CoV-2 virus, but how easily Omicron spreads compared to Delta remains unknown. The CDC expects that anyone with Omicron infection can spread the virus to others, even if they are vaccinated or don’t have symptoms.

Vaccines remain the best way to reduce your risk of severe illness, hospitalization, and death from COVID-19. Current vaccines are expected to protect against severe illness, hospitalizations, and deaths due to infection with the Omicron variant. However, breakthrough infections in people who are fully vaccinated are likely to occur. With other variants, like Delta, vaccines have remained effective at preventing severe illness, hospitalizations, and death. The recent emergence of Omicron further emphasizes the importance of vaccination and boosters.

Masks offer protection against all variants. CDC continues to recommend wearing a mask in public indoor settings in areas of substantial or high community transmission , regardless of vaccination status.

For more information, visit the CDC’s page on variants .